Genetically engineered commensal bacteria are promising living drugs, however, drug delivery is limited to bacterial colonization site. Here, the authors report an oral protein delivery technology utilizing an engineered bacterial type zero secretion system (T0SS) via outer membrane vesicles (OMVs).
